284 related articles for article (PubMed ID: 15342912)
1. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
Aoki M; Jiang H; Vogt PK
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13613-7. PubMed ID: 15342912
[TBL] [Abstract][Full Text] [Related]
2. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
Aoki M; Blazek E; Vogt PK
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):136-41. PubMed ID: 11134523
[TBL] [Abstract][Full Text] [Related]
3. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome.
Plas DR; Thompson CB
J Biol Chem; 2003 Apr; 278(14):12361-6. PubMed ID: 12517744
[TBL] [Abstract][Full Text] [Related]
4. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
5. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.
Bader AG; Felts KA; Jiang N; Chang HW; Vogt PK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12384-9. PubMed ID: 14530393
[TBL] [Abstract][Full Text] [Related]
6. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.
Hu MC; Lee DF; Xia W; Golfman LS; Ou-Yang F; Yang JY; Zou Y; Bao S; Hanada N; Saso H; Kobayashi R; Hung MC
Cell; 2004 Apr; 117(2):225-37. PubMed ID: 15084260
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
Bader AG; Vogt PK
Mol Cell Biol; 2005 Mar; 25(6):2095-106. PubMed ID: 15743808
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
10. Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt.
Nakae J; Kitamura T; Ogawa W; Kasuga M; Accili D
Biochemistry; 2001 Oct; 40(39):11768-76. PubMed ID: 11570877
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
[TBL] [Abstract][Full Text] [Related]
12. The akt kinase: molecular determinants of oncogenicity.
Aoki M; Batista O; Bellacosa A; Tsichlis P; Vogt PK
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14950-5. PubMed ID: 9843996
[TBL] [Abstract][Full Text] [Related]
13. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation.
Matsuzaki H; Daitoku H; Hatta M; Tanaka K; Fukamizu A
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11285-90. PubMed ID: 13679577
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.
Jiang BH; Zheng JZ; Aoki M; Vogt PK
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1749-53. PubMed ID: 10677529
[TBL] [Abstract][Full Text] [Related]
15. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
16. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
Bai D; Ueno L; Vogt PK
Int J Cancer; 2009 Dec; 125(12):2863-70. PubMed ID: 19609947
[TBL] [Abstract][Full Text] [Related]
17. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
18. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
[TBL] [Abstract][Full Text] [Related]
19. The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4.
Goruppi S; Kyriakis JM
J Biol Chem; 2004 May; 279(20):20950-8. PubMed ID: 15016802
[TBL] [Abstract][Full Text] [Related]
20. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
